Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Botanix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Australian biotech sector continues to be a magnet for US investors
News
Market Highlights: Wall Street falls sharply as tech momentum fades; Betashares says build strong core first
Health & Biotech
Weed Week: Mastercard says NO to cannabis transactions, as New York becomes the happening place for weed
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
These were the best ASX biotechs as Health Care sprang back to life in FY23
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
Health & Biotech
Weed Week: Storm before the calm as cannabis market set to boom after SAFE Banking Act passed
Health & Biotech
The Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreak
News
In Case You Missed It: Nickel finds, air compressors and high grade niobium
Health & Biotech
ASX Health Stocks: OncoSil to commence trial; Korea and Malaysia next stops for these biotechs
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Brokers see blue sky for these 3 ASX biotech stocks, with massive price targets
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX climbs ahead of Australia’s Richest Morning Tea™ tomorrow at the RBA
Health & Biotech
ASX Health Stocks: PYC to take second asset to clinical trial; FDA sees no issues in Botanix submission
Health & Biotech